Home
    • Plans Blog Contact
    PERRIGO Co plc logo

    PERRIGO Co plc

    PRGO
    Last price US$10.09
    Market cap US$1.4b
    12M price change -64.12%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Gelteq LtdGELS Industry peer New You, Inc.NWYU Industry peer RCMW Group, Inc.RCMW Industry peer Zoetis IncZTS Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    PERRIGO Co plc Overview

    Industry: Drug Manufacturers-Specialty & Generic

    Sector: Healthcare

    Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in Ireland, the United States, France, Belgium, China, the United Kingdom, Germany, Switzerland, Austria, Italy, Australia, Greece, and Spain. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The Consumer Self-Care Americas segment develops, manufacture, and markets self-care products including upper respiratory, pain and sleep-aids, digestive health, nutrition, healthy lifestyle, skincare, women's health, and other products, as well as vitamins, minerals and supplements, and oral self-care in the United States and Canada. This segment offers its products under Burt's Bees, Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, and Steripod brands. Consumer Self-Care International segment comprises consumer self-care product categories outside the U.S. and Canada, including branded products in Europe and Australia, and store brand products in the United Kingdom and parts of Europe and Asia, which develops, manufactures, markets, and distributes consumer self-care brands through a network of drug and grocery store retailers, e-commerce stores, and para-pharmacies in more than 29 countries, primarily in Europe. In addition, the company offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in Ireland, the United States, France, Belgium, China, the United Kingdom, Germany, Switzerland, Austria, Italy, Australia, Greece, and Spain. It operates through Consumer Self-Care Americas Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for PERRIGO Co plc into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed May 06, 2026

    Quarterly result summary

    Net sales was $842M (reported); EPS was $0.43 (reported).

    Net sales $842M reported
    EPS $0.43 reported
    Operating income $116 reported
    Net income -$398.6M +6128% YoY

    What changed

    • Net sales reported to $842M; EPS reported to $0.43.
    • Net income +6128% YoY to -$398.6M.
    • net sales growth on an organic basis, which excludes acquisitions, divestitures and exited products, and the impact of currency,.

    Guidance / outlook

    we expect to continue to experience and report restructuring-related charges associated with continued execution of our strategic initiatives.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing 10-Q May 06, 2026 SEC filing 8-K Apr 22, 2026 Earnings release Earnings release Feb 26, 2026 SEC filing 10-K Feb 26, 2026 Earnings release Earnings release Nov 05, 2025 SEC filing 10-Q Nov 05, 2025 SEC filing 10-Q Aug 06, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 3.00/5
    PERRIGO Co plc boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Drug Manufacturers-Specialty & Generic industry , Gelteq Ltd , New You, Inc. , RCMW Group, Inc. are companies with high ratings.

    Return on Equity

    Score 1.96/5
    PERRIGO Co plc exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    PERRIGO Co p... PRGO US$1.4b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 3.36/5
    PERRIGO Co plc commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    PERRIGO Co p... PRGO US$1.4b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Drug Manufacturers-Specialty & Generic industry , Gelteq Ltd , New You, Inc. , RCMW Group, Inc. are companies with high ratings.

    Leverage

    Score 3.00/5
    PERRIGO Co plc attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc , also exhibit high scores.
    PERRIGO Co p... PRGO US$1.4b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    PERRIGO Co plc logo

    PERRIGO Co plc

    US$10.09

    US$1.4b

    -5.88%

    -64.12%